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106a Sunday, February 8, 2015myocytes in comparison to their ventricular counterpart. Furthermore, our lab-
oratory recently found that in atrial cells that underwent rapid atrial pacing
(RAP) to simulate pathological effects of atrial fibrillation, the buffering
strength was increased. This resulted in smaller central CaT amplitudes and
comparable sub-sarcolemmal CaT amplitudes with respect to control cells. In
this project we seek to test the effect of buffering in the LCC and its role in
the CaT spatiotemporal profile. To elucidate these effects, we performed patch
clamp experiments to investigate the differences in the LCC function under
different buffering conditions. We incorporated these findings in a minimized
spatial computational model to evaluate the impact of buffering and TTs on
intracellular Ca2þ signals. This ongoing work seeks to investigate the mecha-
nisms that lead to different spatiotemporal profiles of the CaT and how these
differences affect atrial cell function. This work should broaden our under-
standing of atrial cell function in health and disease.
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Invaginations of the cellular membrane called t-tubules are essential for main-
taining efficient excitation-contraction coupling in ventricular cardiomyocytes.
Disruption of t-tubule structure during heart failure promotes dyssynchronous,
slowed Ca2þ release and reduced power of the heartbeat. While the triggers of
t-tubule disruption remain poorly understood, recent evidence suggests that loss
of junctophilin-2, a t-tubule anchor, may be critically involved. We presently
investigated whether ventricular wall stress following myocardial infarction
predicts loss of junctophilin-2, t-tubular structure, and disruption of Ca2þ ho-
meostasis. Phase contrast MRI and blood pressure measurements were em-
ployed to examine regional ventricular wall stress in the left ventricle of
failing, post-infarction, rat hearts in comparison with sham-operated controls.
Markedly elevated diastolic blood pressure resulted in increased wall stress
in failing hearts, particularly in regions proximal to the infarct where the ven-
tricular wall was thinned (Wall stress ¼ 61.856.4kN/m2 proximal zone vs
31.654.0kN/m2 sham). Wall stress measurements across failing hearts corre-
lated strongly with junctophilin-2 expression, which was reduced in the prox-
imal but not distal zones. A corresponding disruption of t-tubule organization
and density was observed in the proximal zone (t-tubule fraction ¼
18.950.4% sham vs 17.150.6% proximal zone), and Ca2þ transients were
significantly desynchronized and slowed. In agreement with local disruption
of cardiomyocyte structure and Ca2þ homeostasis, in vivo strain was dramati-
cally reduced in the proximal zone, with near isometric contraction observed.
Strain measurements in the distal zone of infarcted hearts were unaltered
from equivalent regions in sham. Thus, regional in vivo wall stress effectively
predicts cardiomyocyte-level disruption of structure and function in the post-
infarction failing heart, which in turn promotes reduced in vivo contractile
function. These findings are consistent with a key role of mechanotransduction
in signaling cardiomyocyte structural degradation during heart failure.
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Rationale: SERCA2 controls cardiac contractility, and its activity is negatively
regulated by the cAMP phosphodiesterase PDE3A through an unknown mech-
anism. Recent clinical trials have shown upregulation of SERCA2 gene therapy
as beneficial in heart failure.
Objective: To examine whether PDE3A is physically associated with SERCA,
and to further evaluate whether this protein interaction represent a novel drug
target to increase SERCA2 activity.
Methods and results: PDE3 inhibition increased Ca2þ transients, SR Ca2þ load
and SERCA2 activity without altering global cytosolic cAMP levels in field
stimulated cardiomyocytes. SERCA2 activitywas increased by PDE3 inhibition
in cardiomyocytes dialyzed with 5 mmol/l cAMP by patch pipettes. Active
PDE3A co-purified and precipitated with SERCA2 from left ventricular
myocardium, and proximity ligation assay demonstrated co-localization of
PDE3A and SERCA2 in intact cardiomyocytes. A combination of immunopre-
cipitation and peptide interaction experiments revealed interaction between spe-
cific cytosolic regions between amino acids 277 and 493 in PDE3A and amino
acid 169 to 216 in SERCA2. By whole cell voltage clamp of intact cardiomyo-
cytes, increased SERCA2 activity was induced by dialysis with disruptor pep-
tides of the SERCA2-PDE3A interaction. TAT-labeled PDE3A-SERCA2
disruptor peptide fragments were further able to increase SERCA2 activity infield stimulated cardiomyocytes. PDE3A-SERCA2 disruptor peptides were
able to increase SERCA2 activity in cardiomyocytes in presence of either PKI
or Rp-cAMP and without concomitant phospholamban phosphorylation.
Conclusion: PDE3A is physically associated to SERCA2, and this direct inter-
action regulates SERCA2 activity in cardiomyocytes possibly by direct regula-
tion of SERCA2. Cell permeable disruptor peptides of the PDE3A-SERCA2
protein-protein interaction is able to increase SERCA2 activity and may poten-
tially offer a new therapeutic approach in chronic heart disease.
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Higher risk of developing life threatening cardiac arrhythmias, such as atrial
fibrillation (AF) has been found in type 2 diabetes mellitus (T2DM), but the
mechanism underlying the association is largely unknown. Our previous
studies showed that circulating IgGs from certain advanced T2DM patients dis-
played anti-endothelial effects and often induced intracellular Ca release in
endothelial cells. The present study is to test the hypothesis that circulating
IgGs from T2DM patients with AF perturb intracellular Ca homeostasis in
atrial cardiomyocytes which in turn trigger AF. Protein A-purified IgGs were
obtained from a cohort of T2DM subjects with AF and subjects without AF
or other cardiovascular complications. The data show that IgG (1 mg/mL)
from T2DMAF patients caused acute intracellular Ca release in cultured mouse
atrial cardiomyocytes HL-1 cells compared to control groups (p < 0.001). The
IgG-mediated Ca release was insensitive to verapamil (20 mM), mibefradil (25
mM) or BTP-2 (5 mM), indicating that the Ca release is not through voltage-
gated Ca channels or store-operated Ca entry. On the other hand, application
of Xestospongin C (10 mM) or 2-APB (100 mM), two membrane-permeable
IP3 receptor antagonists, or knockdown of IP3 receptor, significantly decreased
Ca release stimulated by the IgGs from T2DM AF patients (p < 0.01). Taken
together, our data suggest that circulating IgGs alter intracellular Ca homeosta-
sis in cardiomyocytes through IP3 pathway in T2DM AF patients. Our studies
may provide the mechanistic understanding on a causal role of circulating IgGs
in T2DM patients with AF and other symptomatic cardiac conduction diseases.
The IgGs may serve as a biomarker for identifying a subset of T2DM patients
with increased risk for development of AF.
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Alternans has been linked to the onset of ventricular fibrillation and ventricular
tachycardia, leading to life-threatening arrhythmias. Experimentally electrome-
chanical alternans can be either concordant (Long/Short APD corresponds to a
Large/Small Ca transient on alternate beats) or discordant (Long/Short APD
corresponds to a Small/Large Ca transient). Our previous studies have shown
that these phenomena depend on the underlying instability mechanisms
(voltage driven or Ca driven) and bi-directional coupling between voltage
and Ca cycling. The Large Ca transients also cause larger contractions which
can activate mechanically (or stretch) activated currents (SACs). Here, we
show how SAC activation can feed back to alter cardiac alternans, using a phys-
iologically detailed rabbit AP and Ca cycling model coupled with SAC (either
as Cl current or nonselective cation current). We found that (1) SAC suppresses
electromechanically concordant alternans, because SAC shortens longer APD
more than the shorter APD and limits the difference between successive
APDs, (2) SAC enhances electromechanically discordant alternans, because
SAC shortens the Short APD more than Long APD which amplifies the differ-
ence of two successive APDs. Qualitatively similar results were found for Cl-
selective and non-selective cation current (and also Ca-activated K current).
These results suggest that mechano-electric feedback can play an important
role in development and stability of cardiac alternans.
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Natriuretic peptides (NPs) play a pivotal role in the regulation of intravascular
volume by modulating blood vessel tone and renal function. Elevated B-type
